Draper is developing an e-field sensor that may redefine the ECG—enabling direct measurement of the heart’s three-dimensional (3D) bioelectric field.
Draper is excited to collaborate with Kite Pharma to enhance Kite’s development of pipeline cell therapies using our engineering services and portfolio of cell bioprocessing technologies.
Check out your Company Bowl for anonymous work chats.
